Symposium Explores Clinical Trial Design and Multidrug Resistance in Blood Cancers
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
Cody Wolf was one of 19 young scientists who visited Washington for AACR's Early-career Hill Day.
Event cochair Dr. Michael Caligiuri shares how attendees can form connections to take science from bench to market.
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...
AACR will host the inaugural Blood Cancer Discovery Symposium March 4-6, 2024, featuring experts from all areas of blood...
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful...
Charles Swanton, MD, PhD, FAACR, spoke on the role chromosomal instability plays in breast cancer evolution.
“What will you do Monday morning?” was the question posed by the final session on the final full day...
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and...
Studies featured at this year’s San Antonio Breast Cancer Symposium (SABCS) suggest that—in some situations—adjuvant radiotherapy may not be...